Authority: IC 13-13-5-1; IC 13-14-8-2; IC 13-14-8-7; IC 13-18-3-2
Affected: IC 13-12-3-1; IC 13-13-5-2; IC 13-14-9; IC 13-18-11
Sec. 2.
Disinfection Byproduct | MCL (mg/L) |
TTHM | 0.080 |
HAA5 | 0.060 |
Bromate | 0.010 |
Chlorite | 1.0 |
Disinfection Byproduct | Best Available Technology |
TTHM | Enhanced coagulation or enhanced softening, or GAC10, with chlorine as the primary and residual disinfectant. |
HAA5 | Enhanced coagulation or enhanced softening, or GAC10, with chlorine as the primary and residual disinfectant. |
Bromate | Control of ozone treatment process to reduce production of bromate. |
Chlorite | Control of treatment processes to reduce disinfectant demand and control of disinfection treatment processes to reduce disinfectant levels. |
Disinfection Byproduct | MCL (mg/L) |
TTHM | 0.080 |
HAA5 | 0.060 |
Disinfection Byproduct | Best Available Technology |
TTHM and HAA5 | Enhanced coagulation plus GAC10, enhanced softening plus GAC10, or nanofiltration with a molecular weight cutoff less than or equal to one thousand (1,000) Daltons, or GAC20. |
Disinfection Byproduct | Best Available Technology |
TTHM and HAA5 | Systems serving greater than or equal to ten thousand (10,000): Improved distribution system and storage tank management to reduce residence time, plus the use of chloramines for disinfectant residual maintenance. Systems serving less than ten thousand (10,000): Improved distribution system and storage tank maintenance to reduce residence time. |
327 IAC 8-2.5-2